GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shenzhen Bioeasy Biotechnology Co Ltd (SZSE:300942) » Definitions » COGS-to-Revenue

Shenzhen Bioeasy Biotechnology Co (SZSE:300942) COGS-to-Revenue : 0.48 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen Bioeasy Biotechnology Co COGS-to-Revenue?

Shenzhen Bioeasy Biotechnology Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥23.5 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥49.3 Mil.

Shenzhen Bioeasy Biotechnology Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.48.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shenzhen Bioeasy Biotechnology Co's Gross Margin % for the three months ended in Mar. 2025 was 52.37%.

Shenzhen Bioeasy Biotechnology Co COGS-to-Revenue Historical Data

The historical data trend for Shenzhen Bioeasy Biotechnology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Bioeasy Biotechnology Co COGS-to-Revenue Chart

Shenzhen Bioeasy Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.25 0.28 0.43 0.50 0.29

Shenzhen Bioeasy Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.35 0.39 0.19 0.48

Shenzhen Bioeasy Biotechnology Co COGS-to-Revenue Calculation

Shenzhen Bioeasy Biotechnology Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=65.867 / 224.249
=0.29

Shenzhen Bioeasy Biotechnology Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=23.502 / 49.343
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Bioeasy Biotechnology Co  (SZSE:300942) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shenzhen Bioeasy Biotechnology Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 23.502 / 49.343
=52.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shenzhen Bioeasy Biotechnology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shenzhen Bioeasy Biotechnology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Bioeasy Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shenzhen Bioeasy Biotechnology Co Ltd (SZSE:300942) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:002868 SZSE:300381 SZSE:300858 SZSE:300149 SHSE:688399 SZSE:300653 SZSE:300238 SHSE:688238 SZSE:300583 SHSE:688202 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Liuxian 1st Road, Xin'an Street, 101, Yirui Biological Building, Xingdong Community, Bao'an District, Guangdong Province, Shenzhen, CHN, 518101
Website
http://www.bioeasy.com
Shenzhen Bioeasy Biotechnology Co Ltd is dedicated towards food and drug safety, clinical diagnosis, public safety and other fields. It produces and sells clinical diagnosis products. It develops testing products for nine areas closely related to people's lives which include food safety, agricultural product safety, dairy product safety, meat safety, aquatic product safety, honey safety, clinical diagnosis, drug safety, and public safety.
Executives
Fu Hui Directors, executives

Shenzhen Bioeasy Biotechnology Co Headlines

No Headlines